United Therapeutics Corp
NASDAQ:UTHR
United Therapeutics Corp
NASDAQ:UTHR
Price:
275.13 USD
1.73%
Market Closed
Updated:
May 31, 2024
United Therapeutics Corp
Other Long-Term Assets
|
United Therapeutics Corp
Other Long-Term Assets Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
United Therapeutics Corp
NASDAQ:UTHR
|
Other Long-Term Assets
$565.2m
|
CAGR 3-Years
9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
8%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Long-Term Assets
$9.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
51%
|
CAGR 10-Years
27%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Long-Term Assets
$4.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
25%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Long-Term Assets
$9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
39%
|
CAGR 10-Years
19%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Long-Term Assets
$2.8B
|
CAGR 3-Years
49%
|
CAGR 5-Years
13%
|
CAGR 10-Years
75%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Long-Term Assets
$3.2B
|
CAGR 3-Years
55%
|
CAGR 5-Years
27%
|
CAGR 10-Years
29%
|
See Also
What is United Therapeutics Corp's Other Long-Term Assets?
Other Long-Term Assets
565.2m
USD
565.2m
USD
Based on the financial report for Mar 31, 2024, United Therapeutics Corp's Other Long-Term Assets amounts to 565.2m USD.
What is United Therapeutics Corp's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
8%
8%
Over the last year, the Other Long-Term Assets growth was 27%. The average annual Other Long-Term Assets growth rates for United Therapeutics Corp have been 9% over the past three years , 3% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet
